Canadian Cancer Trials Group Bulletins


Upcoming International Meeting

TAT 2015 will offer the latest on new molecular and immunological targets and agents for innovative cancer therapies, in particular the most promising ones in early-phase clinical development in a confined setting with only plenary sessions. Owing to its medium size, TAT 2015 offers excellent opportunities for networking with the world's leaders in oncology phase 1 studies from academia and industry.

For more information and to register, please visit this website ...